Svas Biosana S.p.A. (IT:SVS)
:SVS
Want to see IT:SVS full AI Analyst Report?
SVS Stock Chart & Stats
€9.00
€0.10(1.42%)
At close: 4:00 PM EST
€9.00
€0.10(1.42%)
Day’s Range― - ―
52-Week Range€7.30 - €10.80
Previous CloseN/A
Volume1.97K
Average Volume (3M)5.93K
Market Cap
€48.94M
Enterprise Value€89.95M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.5
Beta0.44
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,600,000
10 Day Avg. Volume10,774
30 Day Avg. Volume5,926
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)1.46
Revenue Forecast (FY)€151.30M
Bulls Say, Bears Say
Bulls Say
Operating Margin ExpansionThe strong performance of the medical device distribution business in Eastern Europe continues to support operating margin expansion, which reached 12.7%.
Revenue GrowthSvas Biosana delivered a solid 1Q 2025 with revenues of €32.7m (+14.3% YoY, +6.6% standalone), driven by recent acquisitions and strong momentum in the Balkans.
Strategic ExpansionSvas Biosana strengthens its positioning in the distribution of medical devices to public healthcare institutions by acquiring 51% of Mehos Srl, marking a new step in the company’s external growth strategy.
Bears Say
Revenue DeclineThe strategic repositioning towards higher-margin services led to a decline in the Svas and Medical divisions, which recorded revenues of €20.2m (-12.6% YoY) and €8.2m (-11.8% YoY), respectively.
Svas Biosana S.p.A. News
SVS FAQ
What was Svas Biosana S.p.A.’s price range in the past 12 months?
Svas Biosana S.p.A. lowest stock price was €7.30 and its highest was €10.80 in the past 12 months.
What is Svas Biosana S.p.A.’s market cap?
Svas Biosana S.p.A.’s market cap is €48.94M.
When is Svas Biosana S.p.A.’s upcoming earnings report date?
Svas Biosana S.p.A.’s upcoming earnings report date is Sep 24, 2026 which is in 147 days.
How were Svas Biosana S.p.A.’s earnings last quarter?
Currently, no data Available
Is Svas Biosana S.p.A. overvalued?
According to Wall Street analysts Svas Biosana S.p.A.’s price is currently Overvalued.
Does Svas Biosana S.p.A. pay dividends?
Svas Biosana S.p.A. does not currently pay dividends.
What is Svas Biosana S.p.A.’s EPS estimate?
Svas Biosana S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Svas Biosana S.p.A. have?
Svas Biosana S.p.A. has 5,600,000 shares outstanding.
What happened to Svas Biosana S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Svas Biosana S.p.A.?
Currently, no hedge funds are holding shares in IT:SVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Garofalo Health Care S.P.A.
―
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Farmae SpA
―
I.M.D. International Medical Devices S.P.A.
―
Options Prices
Currently, No data available
---